PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: skutsuna@hosp.ncgm.go.jp.\', \'AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.\', \'Department of Intractable Diseases, National Center for Global Health and Medicine, Tokyo, Japan.\', \'Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.\', \'Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: ssaito@hosp.ncgm.go.jp.\', \'Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.\', \'Department of Respiratory Diseases, National Center for Global Health and Medicine, Tokyo, Japan.\', \'Department of Intractable Diseases, National Center for Global Health and Medicine, Tokyo, Japan; Vice Director-General, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1341-321X(21)00014-310.1016/j.jiac.2021.01.006
?:doi
?:hasPublicationType
?:journal
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
is ?:pmid of
?:pmid
?:pmid
  • 33531292
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all